Trial Profile
A double-blind controlled pilot study of high-dose capsaicin patches in the treatment of pain associated with postherpetic neuralgia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2010
Price :
$35
*
At a glance
- Drugs Capsaicin (Primary)
- Indications Neuropathic pain; Postherpetic neuralgia
- Focus Therapeutic Use
- 02 Sep 2010 Results of a planned pooled analysis of this trial and 3 other RCTs [700005965, 700014824 and 700027018] were presented at the 13th World Congress on Pain.
- 25 Oct 2005 New trial record.